AMTI Applied Molecular Transport Inc

Price (delayed)

$28.42

Market cap

$1.09B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.06

Enterprise value

$942.42M

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, ...

Highlights
The company's quick ratio has surged by 101% QoQ and by 3.5% YoY
Applied Molecular Transport's equity has soared by 83% from the previous quarter and by 26% YoY
The net income has plunged by 72% YoY and by 12% from the previous quarter
Applied Molecular Transport's debt has soared by 66% from the previous quarter

Key stats

What are the main financial stats of AMTI
Market
Shares outstanding
38.42M
Market cap
$1.09B
Enterprise value
$942.42M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.23
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$79.97M
EBITDA
-$75.86M
Free cash flow
-$76.81M
Per share
EPS
-$2.06
Free cash flow per share
-$2.01
Book value per share
$5.44
Revenue per share
$0
TBVPS
$5.88
Balance sheet
Total assets
$224.27M
Total liabilities
$16.18M
Debt
$10.88M
Equity
$208.09M
Working capital
$197.76M
Liquidity
Debt to equity
0.05
Current ratio
25.27
Quick ratio
24.61
Net debt/EBITDA
1.97
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-49.3%
Return on equity
-53.1%
Return on invested capital
-74.4%
Return on capital employed
-37%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMTI stock price

How has the Applied Molecular Transport stock price performed over time
Intraday
3.76%
1 week
5.81%
1 month
-8.32%
1 year
-11.74%
YTD
-7.64%
QTD
-37.87%

Financial performance

How have Applied Molecular Transport's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$80.02M
Net income
-$79.97M
Gross margin
N/A
Net margin
N/A
The net income has plunged by 72% YoY and by 12% from the previous quarter
Applied Molecular Transport's operating income has plunged by 71% YoY and by 12% from the previous quarter

Growth

What is Applied Molecular Transport's growth rate over time

Valuation

What is Applied Molecular Transport stock price valuation
P/E
N/A
P/B
5.23
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
AMTI's EPS has surged by 61% year-on-year and by 19% since the previous quarter
Applied Molecular Transport's equity has soared by 83% from the previous quarter and by 26% YoY
AMTI's P/B is 46% below its last 4 quarters average of 9.4

Efficiency

How efficient is Applied Molecular Transport business performance
The return on invested capital has dropped by 128% year-on-year and by 31% since the previous quarter
The ROE has plunged by 89% YoY and by 3.5% from the previous quarter
Applied Molecular Transport's ROA has plunged by 83% YoY and by 2.7% from the previous quarter

Dividends

What is AMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMTI.

Financial health

How did Applied Molecular Transport financials performed over time
AMTI's total liabilities has surged by 114% year-on-year and by 26% since the previous quarter
The current ratio has soared by 101% QoQ and by 4.8% YoY
Applied Molecular Transport's debt is 95% less than its equity
Applied Molecular Transport's equity has soared by 83% from the previous quarter and by 26% YoY
Applied Molecular Transport's debt has soared by 66% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.